Your browser doesn't support javascript.
loading
Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study.
Schmidinger, Manuela; Motzer, Robert J; Rolland, Frederic; Staehler, Michael; Rink, Michael; Retz, Margitta; Csoszi, Tibor; McCaffrey, John A; De Giorgi, Ugo; Caserta, Claudia; Duran, Ignacio; Benzaghou, Fawzi; Clary, Douglas O; Albiges, Laurence; Choueiri, Toni K; Tannir, Nizar M.
Afiliación
  • Schmidinger M; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rolland F; Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
  • Staehler M; Department of Urology, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Retz M; Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany.
  • Csoszi T; Jász-Nagykun-Szolnok County Hospital, Szolnok, Hungary.
  • McCaffrey JA; Cancer Trials Ireland, Dublin, Ireland.
  • De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Caserta C; Medical and Translational Oncology Unit, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Duran I; Medical Oncology Department, Hospital Universitario Marques de Valdecilla (IDIVAL), Santander, Spain.
  • Benzaghou F; Ipsen Bioscience, Oncology R&D, Cambridge, MA, USA.
  • Clary DO; Exelixis Inc., Alameda, CA, USA.
  • Albiges L; Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tannir NM; MD Anderson Cancer Center Hospital, The University of Texas, Houston, TX, USA.
Acta Oncol ; 61(1): 52-57, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34736367
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Austria